Green Cross Cell is Biotechnology in South Korea that focus on CROSS CELL CORP manufactures business. Founded in 1992. They cover business area such as GREEN CROSS CELL CORP manufacture, immunotherapy drug, South Korea, Immuncell-LC, patient, whose tumor, curative resection, Hepatocellular Carcinoma, cord blood cryopreservation activity, clinical trial, liver cancer, brain tumor, pancreatic cancer, colorectal cancer.
1992
( 32 years old in 2024 )
CROSS CELL CORP Manufactures
-
6th floor, 278, Beotkkot-ro
Geumcheon-gu
Seoul, 08511
South Korea
Private
GREEN CROSS CELL CORP manufactureimmunotherapy drugSouth KoreaImmuncell-LCpatientwhose tumorcurative resectionHepatocellular Carcinomacord blood cryopreservation activityclinical trialliver cancerbrain tumorpancreatic cancercolorectal cancer
* We use standard office opening hours in near Green Cross Cell's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Green Cross Cell is Biotechnology business from South Korea that founded in 1992 (32 years old in 2024), Green Cross Cell business is focusing on CROSS CELL CORP Manufactures.
Green Cross Cell headquarter office and corporate office address is located in 6th floor, 278, Beotkkot-ro Geumcheon-gu Seoul, 08511 South Korea.
Green Cross Cell was founded in South Korea.
In 2024, Green Cross Cell is currently focus on CROSS CELL CORP manufactures sector.
Above is snippet of Google Trends for "CROSS CELL CORP manufactures" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Green Cross Cell, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
